Bicycle Therapeutics plc announced the pricing of an underwritten public offering of 9,411,766 American Depositary Shares, each representing one ordinary share and, in lieu of ADSs to investors that so choose, non-voting ordinary shares, each at a price to the public of $21.25 per share, for gross proceeds of approximately $200.0 million.
